- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03386110
Couples Health Project: Couples-based Intervention to Reduce Drug Use and HIV Transmission Risk (CHP)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study aims to evaluate a couples-based intervention with an integrated focus on drug use and HIV prevention, including uptake of and adherence to PrEP. The investigators will recruit a sample of 50 couples (n = 100 individuals)
Recruitment occurs using a mix of in-person and Internet recruitment. Outreach workers will visit bars and events in the New York City area to recruit participants. Also, information on our project will be posted on social media sites (e.g.,Facebook, Grindr, Scruff). Interested individuals will complete a brief online screener to assess eligibility.
A telephone screener will be conducted with participants who are preliminarily eligible based upon online screener responses. Participants who are eligible based upon telephone screening responses will be sent two emails. The first contains a link for them to access the baseline online survey. The second email is for them to forward to their partner. It provides information which introduces the study to the recruited partner and a link to the baseline survey online. If participants indicate intimate partner violence (IPV) on the online baseline survey, participants will be rendered ineligible. Only the participant that indicated experiencing IPV will be given a list of local referrals to access IPV-related services.
An in-person baseline assessment appointment will be scheduled after both participants have completed the online survey. If participants come to the research site alone, they will need to reschedule the appointment when both partners can attend.
The in-person baseline assessment appointment consists of four components; written consenting, a computer-assisted self interview (CASI), a timeline follow back interview, and biological testing.
Written consent is obtained with each participant individually in separate rooms. Participants additionally complete a computer-assisted self interview (CASI) independently. After this, participants will independently complete a TFLB.
TLFB is a semi-structured interview to collect retrospective event-level data on drug use, sexual behavior and PrEP adherence (for those on PrEP) in the past 30 days. Participants complete the survey and TLFB independently in a different room, without their partner.
The final part of the in-person baseline assessment consists of biological testing for STI (gonorrhea & chlamydia via urinalysis and rectal swabs), drug testing via 5-panel fingernail drug assay via finger or toe nail clippings. Drugs tested are 5 major drugs: Amphetamines, Cannabinoids, Cocaine, Opiates, and Phencyclidine (PCP).
After the baseline assessment, participants will be randomized to receive their first CHP or Education session, of which the first session will occur immediately following their baseline assessment. The study will employ a stratified randomization procedure using an algorithm via Qualtrics. Couples will be randomized using three couple-level criteria. Couples will be randomized based on relationship length difference (less than 2 years versus 2 or more), age difference (less than 3 years versus 3 or more), and racial difference (both white versus all others combinations). Each of the intervention arms consists of 3 sessions that occur once a week for three consecutive weeks.
For Session 3 of the experimental and control conditions, participants complete a Couples HIV Testing and Counseling (CHTC) session that involves a rapid HIV testing for couples. HIV testing is done via the Alere Determine HIV-1/2 Ag/Ab Combo blood test. The couple undergo HIV testing together and receive the results together.
All participants complete a 1-month, 3-month, and 6-month follow ups. Follow-up appointments are scheduled with each participant independently (not as a couple). For the 1 month follow up (post baseline assessment), participants will complete an online survey at home for which participants are instructed to take this survey independent from their partner. At the 3 month follow up (post baseline assessment), participants complete a survey with a TLFB and Fingernail specimen collection for drug use at the research office. At the 6 month follow up (post baseline assessment), participants complete a survey with a TLFB and biological specimen collection to test drug use via fingernail sample and Gonorrhea & Chlamydia for STI testing (Urinalysis and Rectal swabs) at the research offices.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10018
- Center for HIV Educational Studies and Training
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- At least one member of the couple must be 18 to 29 years of age
- Both members assigned male gender at birth and currently identify as male
- At least one member of the couple reports an HIV-negative serostatus
- Couple has been together for at least 3 months
- The use of at least one of the following substances in the past 30 days (only one partner): marijuana, cocaine/crack, amphetamines, ecstasy, GHB, ketamine, nitrates, prescriptionn drug misuse
- At least one member of the couple, in the past 30 days, had condomless anal sex (CAS) with a casual partner and/or CAS with a non-monogamous or serodiscordant main partner.
- Both members must be able to communicate in English
- Both members must reside in the NYC metro area
Exclusion Criteria:
- Either member of the couple reports IPV, which is defined as serious physical or sexual violence that occurs outside the context of consensual bondage or sado-masochistic sexual play, which results in concerns of safety.
- Inconsistencies between information provided in the eligibility screener and the in-person meeting or any issues that might hinder participation. The couple may also be deemed ineligible if participant responses are sufficiently inconsistent to call into question the validity of their individual responses
- The couple reports a sero-concordant HIV-positive serostatus
- Unstable, serious psychiatric symptoms (assessed at Baseline)
- Currently suicidal/homicidal
- Evidence of gross cognitive impairment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Couples Health Project (CHP)
The CHP intervention is a three session intervention that occurs once a week for three weeks.
The CHP intervention will be delivered by MI-trained mental health counselors.
The CHP intervention is comprised of 3 sessions.
25 couples will be allocated to this arm.
|
The CHP intervention focuses on addresses drug use and HIV transmission risk by enhancing dyadic communication skills and motivation to work towards shared health goals.
The last session of the CHP intervention consists of a Couples HIV Testing and Counseling (CHTC) session.
|
ACTIVE_COMPARATOR: Education
The Education intervention is a attention-matched control three-session intervention that occurs once a week for three weeks.
The education intervention will be delivered by trained health educators.
The education intervention is comprised of 3 sessions.
25 couples will be allocated to this arm.
|
The Education intervention consists of a 3-session health education intervention that addresses sexual risk and substance use through a lecture and question and answer format with a male couple.
Additionally, the last session of the education intervention consists of a Couples HIV Testing and Counseling (CHTC) session.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Illicit Drug Use
Time Frame: Baseline, 3-month follow-up; 6-month follow-up
|
The self-reported number of illicit drug use instances (not including marijuana) in the past 30 days
|
Baseline, 3-month follow-up; 6-month follow-up
|
Number of HIV Transmission Risk Events
Time Frame: 6 months
|
The self-reported number of events of condomless anal sex (CAS) with casual partners in the past 30 days
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Marijuana Use
Time Frame: 6 months
|
The self-reported number of marijuana drug use instances in the past 30 days
|
6 months
|
Collaborators and Investigators
Collaborators
Publications and helpful links
General Publications
- Parsons JT, Lelutiu-Weinberger C, Botsko M, Golub SA. A randomized controlled trial utilizing motivational interviewing to reduce HIV risk and drug use in young gay and bisexual men. J Consult Clin Psychol. 2014 Feb;82(1):9-18. doi: 10.1037/a0035311. Epub 2013 Dec 23.
- Starks TJ, Adebayo T, Kyre KD, Millar BM, Stratton MJ Jr, Gandhi M, Ingersoll KS. Pilot Randomized Controlled Trial of Motivational Interviewing with Sexual Minority Male Couples to Reduce Drug Use and Sexual Risk: The Couples Health Project. AIDS Behav. 2022 Feb;26(2):310-327. doi: 10.1007/s10461-021-03384-9. Epub 2021 Jul 23.
- Starks TJ, Feldstein Ewing SW, Lovejoy T, Gurung S, Cain D, Fan CA, Naar S, Parsons JT. Adolescent Male Couples-Based HIV Testing Intervention (We Test): Protocol for a Type 1, Hybrid Implementation-Effectiveness Trial. JMIR Res Protoc. 2019 Jun 7;8(6):e11186. doi: 10.2196/11186.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Risk Behavior
-
Bournemouth UniversityDorset HealthCare University NHS Foundation TrustWithdrawnRisk Behavior | Violence | Risk Behavior, Health
-
Rhode Island HospitalEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedRisk Behavior | Risk Reduction | Emotion RegulationUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedHealth Behavior | Risk Reduction BehaviorUnited States
-
University of Colorado, DenverSmith-Richardson FoundationCompletedRisk Reduction Behavior | Reproductive BehaviorUnited States
-
University of MiamiEnrolling by invitation
-
Ginger YangUniversity of IowaRecruitingRisk Behavior | Adolescent Behavior | DriveUnited States
-
Pro-Change Behavior SystemsCommunity Health Center, Inc.Unknown
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)RecruitingBehavior, RiskUnited States
-
Lehigh UniversityAlliance of Border Collaboratives; Programa CompañerosUnknownRisk BehaviorUnited States, Mexico
-
Eunice Kennedy Shriver National Institute of Child...Completed
Clinical Trials on Couples Health Project (CHP)
-
Hunter College of City University of New YorkNational Institute on Drug Abuse (NIDA)Not yet recruitingHIV Infections | Substance UseUnited States
-
University of MiamiNational Institute of Mental Health (NIMH)Completed
-
University of Illinois at ChicagoTerminated
-
Rhode Island HospitalRecruitingAdolescent Dating ViolenceUnited States
-
Nova Southeastern UniversityJohn H. Stroger HospitalCompletedRisk Reduction | Unsafe SexUnited States
-
Wesleyan UniversityUniversity of Utah; Military Suicide Research ConsortiumActive, not recruiting
-
University of HoustonRecruiting
-
Kaiser PermanenteWithdrawnType 2 DiabetesUnited States
-
Oregon Research InstituteDrexel UniversityActive, not recruitingOverweight and ObesityUnited States
-
Oregon Research InstituteCompletedObesity | Weight Gain | Eating DisordersUnited States